Cavadex (RemChol) is a formulation of 2-hydroxypropyl-β-cyclodextrin, administered via rectal enema to bypass the digestive system and allow for direct absorption into the bloodstream. This method ensures optimal bioavailability and therapeutic efficacy for reducing arterial plaque and supporting cardiovascular health.
This guide provides a structured approach to the correct administration, dosing regimens, and expected physiological responses, including potential bowel movements and best practices for maximizing absorption.
Method of Administration
1. Preparation
• Select a clean and comfortable space where the procedure can be performed undisturbed.
• Gather the necessary materials, including the Cavadex (RemChol) tube, provided lubrication, and a disposable towel or pad.
• Bowel Preparation: It is advisable to empty the bowels before administration. If this is not possible, administration can still proceed, but absorption may be slightly reduced if stool is present.
2. Lubrication
• Apply a small amount of the provided lubricant to the applicator tip of the enema tube.
• This step ensures a smooth insertion and reduces discomfort.
3. Positioning
• The left lateral recumbent position (lying on the left side with knees bent toward the chest) is recommended for optimal administration.
• Alternative positioning includes the knee chest position, which may facilitate easier insertion.
4. Administration Procedure
• Gently insert the full length of the applicator tip into the rectum.
• Slowly squeeze the entire contents of the Cavadex (RemChol) tube into the rectal cavity.
• Once emptied, carefully remove the applicator and remain in position for at least 30 minutes to facilitate full absorption.
5. Expected Physiological Response
• Bowel Movements: Some users may experience a mild urge to pass stool within 15–45 minutes post administration. This is a natural response to the enema formulation and does not indicate treatment failure.
• Retention of the Solution: If a bowel movement occurs prematurely, some active ingredient may be expelled, though a partial effect is still achieved. If possible, try to retain the solution for at least 30 minutes before voiding.
• No Immediate Sensation: Some individuals may not feel any significant urge and can resume daily activities without issue.
6. Post Administration Care
• Dispose of used tubes in accordance with proper waste management practices.
• If mild leakage occurs, hygienic cleanup with tissue or wipes is recommended.
Dosage and Treatment Recommendations
Standard Dosage
• One enema tube (9g, 12g, or 15g) per day is the recommended standard regimen.
• Administer in the evening, preferably before bedtime, to allow for optimal overnight absorption.
Cavadex Treatment Programs
|
Program Name |
Dosage |
Indications |
|---|---|---|
|
High Program |
1 tube daily (15g) |
For severe cardiovascular conditions requiring aggressive plaque reduction. |
|
Mid Strength Program |
1 tube daily (12g) |
For individuals requiring enhanced cardiovascular support. |
|
Standard Program |
1 tube daily (9g) |
For general cardiovascular health and maintenance. |
|
Maintenance Program |
1 tube (any gram variant) every 2–3 days |
For long-term cardiovascular support following an intensive regimen. |
|
Starter Pack |
1 tube every other day for 2 weeks, then daily |
Recommended for new users to allow gradual adaptation. |
Duration of Use: Long term administration is recommended for sustained cardiovascular benefits. Patients may transition from higher intensity programs to Maintenance dosing over time, based on progress.
Best Practices for Optimal Results
✔ Consistency – Daily administration is key to achieving progressive arterial plaque reduction. Skipping doses may slow treatment outcomes.
✔ Monitoring – Track cardiovascular function, symptom progression, and overall well being throughout the treatment period.
✔ Dietary Considerations – While no dietary restrictions are required, limiting processed foods and excess carbohydrates may enhance treatment effects.
✔ Absorption Timing – To maximize uptake, administer at least 30 minutes before lying down for the night, allowing time for the solution to distribute properly.\
Cavadex (RemChol) is a clinically backed intervention for individuals seeking non invasive cholesterol reduction and arterial plaque management. Correct administration, daily adherence, and an understanding of expected physiological responses are key to maximizing therapeutic outcomes.
Long term use may support cardiovascular function, reduce atherosclerosis progression, and contribute to better overall health outcomes.
For additional guidance or clinical inquiries, contact Cavadex Customer Support via info@cavadex.com
